These findings are in line with the results of quantitative ex vivo immunohistochemical analysis, which revealed higher CD4+ cell densities in the tumor core of therapy-responsive mice and higher CD4+ cell densities in the tumor periphery of two nonresponsive hCD4-KI mice classified with immune excluded PET uptake patterns (Fig. 4, E and F). Here, CD4 is linked to neoplasm.